Evidence map›Paper›PMID 25190258›Full record

ArticleCell research2014

Systematically labeling developmental stage-specific genes for the study of pancreatic β-cell differentiation from human embryonic stem cells.

Haisong Liu, Huan Yang, Dicong Zhu, Xin Sui, Juan Li, Zhen Liang, Lei Xu, Zeyu Chen, Anzhi Yao, Long Zhang and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Purification of Live Stem-Cell-Derived Islet Lineage Intermediates.Current protocols in stem cell biology · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Haisong LiuShenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Huan YangShenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Dicong ZhuShenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Xin SuiShenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Juan LiDepartment of Biomedical Engineering, College of Engineering, Peking University, Beijing 100871, China.
Zhen LiangShenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Lei XuDepartment of Hematopoietic Stem Cell Transplantation, 307 Hospital, Academy of Military Medicine Sciences, Beijing 100071, China.
Zeyu ChenThe MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
Anzhi YaoThe MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
Long ZhangBGI-Shenzhen, Shenzhen, Guangdong 518083, China.
Xi ZhangBGI-Shenzhen, Shenzhen, Guangdong 518083, China.
Xing YiThe MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
Meng LiuShenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Shiqing XuInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Wenjian ZhangInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Hua LinDepartment of Gynecology and Obstetrics, China-Japan Friendship Hospital, Beijing 100029, China.
Lan XieDepartment of Gynecology and Obstetrics, Beijing Renhe Hospital, Beijing 102600, China.
Jinning LouInstitute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Yong ZhangBGI-Shenzhen, Shenzhen, Guangdong 518083, China.
Jianzhong XiDepartment of Biomedical Engineering, College of Engineering, Peking University, Beijing 100871, China.
Hongkui Deng1] Shenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China [2] The MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China [3] Peking University Stem Cell Research Center, Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Peking University · CNChina-Japan Friendship Hospital · CNBGI Group (China) · CNBeijing Hospital · CNCenter for Life Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The applications of human pluripotent stem cell (hPSC)-derived cells in regenerative medicine has encountered a long-standing challenge: how can we efficiently obtain mature cell types from hPSCs? Attempts to address this problem are hindered by the complexity of controlling cell fate commitment and the lack of sufficient developmental knowledge for guiding hPSC differentiation. Here, we developed a systematic strategy to study hPSC differentiation by labeling sequential developmental genes to encompass the major developmental stages, using the directed differentiation of pancreatic β cells from hPSCs as a model. We therefore generated a large panel of pancreas-specific mono- and dual-reporter cell lines. With this unique platform, we visualized the kinetics of the entire differentiation process in real time for the first time by monitoring the expression dynamics of the reporter genes, identified desired cell populations at each differentiation stage and demonstrated the ability to isolate these cell populations for further characterization. We further revealed the expression profiles of isolated NGN3-eGFP(+) cells by RNA sequencing and identified sushi domain-containing 2 (SUSD2) as a novel surface protein that enriches for pancreatic endocrine progenitors and early endocrine cells both in human embryonic stem cells (hESC)-derived pancreatic cells and in the developing human pancreas. Moreover, we captured a series of cell fate transition events in real time, identified multiple cell subpopulations and unveiled their distinct gene expression profiles, among heterogeneous progenitors for the first time using our dual reporter hESC lines. The exploration of this platform and our new findings will pave the way to obtain mature β cells in vitro.

Indexed as

Basic Helix-Loop-Helix ProteinsCell DifferentiationEmbryonic Stem CellsGene Expression ProfilingGenes, ReporterHepatocyte Nuclear Factor 3-betaHumansInsulin-Secreting CellsMembrane GlycoproteinsNerve Tissue ProteinsSequence Analysis, RNASOXF Transcription FactorsBasic Helix-Loop-Helix ProteinsFOXA2 protein, humanHepatocyte Nuclear Factor 3-betaMembrane GlycoproteinsNerve Tissue ProteinsNEUROG3 protein, humanSOX17 protein, humanSOXF Transcription FactorsSUSD2 protein, human

Identifiers

PMID25190258
PMCPMC4185345
OpenAlexW2009225279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.